Patent Yard Sign in
Canadian application, no grantCanada

Extending the lifetime of anticoagulant oligodeoxynucleotide aptamers in blood

CA 2378051 A1 · Owner: The University Of Alberta, Simon Fraser University, The University Of Vi Ctoria, The University Of British Columbia Doing Business As Triumf · Inventors: Dougan, Alfred H.; Weitz, Jeffrey I.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is a complex of a polynucleotide having a property of specifically binding to a target protein together with a protein that stabilizes the polynucleotide from degradation and from clearance from the circulation in vivo. Methods for diagnostic imaging and therapeutic uses of the complex are disclosed.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 22, 2000. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 22, 2020.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 22, 2022.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 22, 2000
GrantedNo grant recorded
Term endedJune 22, 2020
Patent numberCA 2378051 A1
Classification (IPC)A61K51/08 +1 more

Timeline

Timeline From CIPO dates

2001200320052007200920112013201520172019Application filedJune 22, 2000Term endedJune 22, 2020

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.